BB BIOTECH AG As previously announced on July 21, 2023, BB Biotech AG has applied on the same date for the delisting of its shares from Borsa Italiana.
As a result, Borsa Italiana on July 21, 2023, ordered the exclusion of BB Biotech AG's shares (CH0038389992) from trading on the Euronext STAR Milan market segment effective from September 5, 2023. The last day of trading of ordinary shares issued by BB Biotech AG on the Euronext STAR Milan market segment will be September 4, 2023.
The delisting will not affect BB Biotech AG's listings on the SIX Swiss Exchange (SIX) and the Börse Frankfurt (BF). There is no action required from BB Biotech AG's shareholders.
For further information:
Investor Relations
Bellevue Asset Management AG
Seestrasse 16, 8700 Küsnacht, Switzerland, tel. +41 44 267 67 00
Dr. Silvia Siegfried-Schanz, ssc@bellevue.ch
Maria-Grazia Alderuccio, mga@bellevue.ch
Claude Mikkelsen, cmi@bellevue.ch
Media Relations
Bellevue Asset Management AG
Seestrasse 16, 8700 Küsnacht, Switzerland, tel. +41 44 267 67 00
Tanja Chicherio, tch@bellevue.ch
TE Communications AG, Bleichestrasse 11, 9000 St. Gallen, Switzerland, tel. +41 79 423 22 28
Thomas Egger, teg@te-communications.ch
Media release
Download file
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BB Biotech AG published this content on 21 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 August 2023 05:08:10 UTC.
